These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Advances in Heart Failure Management: Improving Outcomes With Innovation. Ibrahim NE; Desai AS; Singh JP; Januzzi JL Rev Cardiovasc Med; 2017; 18(S1):S1-S16. PubMed ID: 28233764 [TBL] [Abstract][Full Text] [Related]
23. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695 [No Abstract] [Full Text] [Related]
24. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction. Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537 [TBL] [Abstract][Full Text] [Related]
25. Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management. Brida M; Diller GP; Gatzoulis MA Circulation; 2018 Jan; 137(5):508-518. PubMed ID: 29378757 [TBL] [Abstract][Full Text] [Related]
26. Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities. Whellan DJ; Adams S; Bowerman L Prog Cardiovasc Dis; 2011; 54(2):107-14. PubMed ID: 21875510 [TBL] [Abstract][Full Text] [Related]
27. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
28. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
29. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
30. Heart failure in children: part II: diagnosis, treatment, and future directions. Hsu DT; Pearson GD Circ Heart Fail; 2009 Sep; 2(5):490-8. PubMed ID: 19808380 [No Abstract] [Full Text] [Related]
31. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185 [TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine-induced cardiomyopathy: a case report. Muthukrishnan P; Roukoz H; Grafton G; Jessurun J; Colvin-Adams M Circ Heart Fail; 2011 Mar; 4(2):e7-8. PubMed ID: 21406675 [No Abstract] [Full Text] [Related]
33. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667 [TBL] [Abstract][Full Text] [Related]
34. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients. Jędrzejczyk-Patej E; Lenarczyk R; Mazurek M; Liberska A; Przybylska-Siedlecka K; Podolecki T; Kowalczyk J; Sokal A; Leopold-Jadczyk A; Kowalski O; Kalarus Z Europace; 2016 Mar; 18(3):436-44. PubMed ID: 26017467 [TBL] [Abstract][Full Text] [Related]